Meritage Portfolio Management’s Cellebrite CLBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $996K | Buy |
62,276
+1,717
| +3% | +$27.5K | 0.06% | 191 |
|
|
2025
Q1 | $1.18M | Buy |
60,559
+30,658
| +103% | +$596K | 0.08% | 183 |
|
|
2024
Q4 | $659K | Buy |
29,901
+2,070
| +7% | +$45.6K | 0.04% | 227 |
|
|
2024
Q3 | $469K | Buy |
27,831
+2,973
| +12% | +$50.1K | 0.03% | 261 |
|
|
2024
Q2 | $297K | Buy |
24,858
+287
| +1% | +$3.43K | 0.02% | 298 |
|
|
2024
Q1 | $272K | Buy |
+24,571
| New | +$272K | 0.02% | 306 |
|